Erythropoietin and amyotrophic lateral sclerosis: Plasma level determination

Amyotrophic Lateral Sclerosis

Volumn 12, Issue 6, 2011, Pages 439-443

  Carilho, Rita ^a   De Carvalho, Mamede ^b,c   Kuehl, Ute ^d   Pinto, Susana ^c   Pinto, Anabela ^c   Kromminga, Arno ^d,e   Costa, Júlia ^a  

^a INSTITUTO DE TECNOLOGIA QUÍMICA E BIOLÓGICA   (Portugal)

^b HOSPITAL DE SANTA MARIA   (Portugal)

^c INSTITUTO DE MEDICINA MOLECULAR   (Portugal)

^d Labor Lademannbogen   (Germany)

^e UNIVERSITY OF KIEL   (Germany)

Author keywords

Amyotrophic lateral sclerosis; erythropoietin; phrenic nerve; plasma; respiratory failure

Indexed keywords

ERYTHROPOIETIN;

ADULT; AGED; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; ARTIFICIAL VENTILATION; CONTROLLED STUDY; DISEASE DURATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FUNCTIONAL DISEASE; FUNCTIONAL STATUS; HUMAN; MAJOR CLINICAL STUDY; MALE; NEUROPROTECTION; NON INVASIVE PROCEDURE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RESPIRATORY FAILURE; RESPIRATORY FUNCTION;

AMYOTROPHIC LATERAL SCLEROSIS; ANIMALS; ANOXIA; ERYTHROPOIETIN; FEMALE; HUMANS; MALE; RESPIRATORY MUSCLES; VENTILATION;

EID: 80055054098     PISSN: 17482968     EISSN: 1471180X     Source Type: Journal    
DOI: 10.3109/17482968.2011.584881     Document Type: Article

References (20)

1. Bruijn LI, Miller TM, Cleveland DW. Unravelling the mechanisms involved in motor neuron degeneration in ALS. Annu Rev Neurosci. 2004;27:723-49. (Pubitemid 39050419)
2. Cleveland DW, Rothstein JD. From Charcot to Lou Gehrig: deciphering selective motor neuron death in ALS. Nat Rev Neurosci. 2001;2:806-19. (Pubitemid 33674062)
3. Levy MM. Pathophysiology of oxygen delivery in respiratory failure. Chest. 2005;128:547-53.
4. Wenger RH. Cellular adaptation to hypoxia: O 2-sensing protein hydroxylases, hypoxia-inducible transcription factors, and O 2-regulated gene expression. FASEB J. 2002;16:1151-62. (Pubitemid 34815403)
5. Semenza GL. Involvement of oxygen-sensing pathways in physiologic and pathologic erythropoiesis. Blood. 2009;114: 2015-9.
6. Brines M, Cerami A. Emerging biological roles for erythropoietin in the nervous system. Nat Rev Neurosci. 2005;6: 484-94. (Pubitemid 40769173)
7. Butsch PO, Cudkowicz ME. Is erythropoietin a potential therapy for amyotrophic lateral sclerosisExp Neurol. 2007; 206:11-5. (Pubitemid 46938638)
8. Siren AL, Fasshauer T, Bartels C, Ehrenreich H. Therapeutic potential of erythropoietin and its structural or functional variants in the nervous system. Neurotherapeutics. 2009;6: 108-27.
9. Lauria G, Campanella A, Filippini G, Martini A, Penza P, Maggi L, et al. Erythropoietin in amyotrophic lateral sclerosis: a pilot, randomized, double-blind, placebo-controlled study of safety and tolerability. Amyotroph Lateral Scler. 2009;10:410-5.
10. Brettschneider J, Widl K, Ehrenreich H, Riepe M, Tumani H. Erythropoietin in the cerebrospinal fl uid in neurodegenerative diseases. Neurosci Lett. 2006;404:347-51. (Pubitemid 44108436)
11. Brettschneider J, Widl K, Schattauer D, Ludolph AC, Tumani H. Cerebrospinal fl uid erythropoietin (EPO) in amyotrophic lateral sclerosis. Neurosci Lett. 2007;416:257-60. (Pubitemid 46483860)
12. Janik P, Kwiecinski H, Sokolowska B, Niebroj-Dobosz I. Erythropoietin concentration in serum and cerebrospinal fl uid of patients with amyotrophic lateral sclerosis. J Neural Transm. 2010;117:343-7.
13. Just N, Moreau C, Lassalle P, Gosset P, Perez T, Brunaud-Danel V, et al. High erythropoietin and low vascular endothelial growth factor levels in cerebrospinal fl uid from hypoxaemic ALS patients suggest an abnormal response to hypoxia. Neuromuscul Disord. 2007;17:169-73.
14. Brooks BR, Miller RG, Swash M, Munsat TL. El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord. 2000;1:293-9.
15. Bremer M, Doerge RW, editors. Statistics at the bench: a step-by-step handbook for biologists. New York: Cold Spring Harbor Laboratory Press; 2010.
16. Moreau C, Gosset P, Brunaud-Danel V, Lassalle P, Degonne B, Destee A, et al. CSF profi les of angiogenic and infl ammatory factors depend on the respiratory status of ALS patients. Amyotroph Lateral Scler. 2009;10:175-81.
17. Embury SH, Garcia JF, Mohandas N, Pennathur-Das R, Clark MR. Effects of oxygen inhalation on endogenous erythropoietin kinetics, erythropoiesis, and properties of blood cells in sickle-cell anaemia. N Engl J Med. 1984;311:291-5. (Pubitemid 14091207)
18. Chikuma M, Masuda S, Kobayashi T, Nagao M, Sasaki R. Tissue-specifi c regulation of erythropoietin production in the murine kidney, brain, and uterus. Am J Physiol Endocrinol Metab. 2000;279:1242-8.
19. Horiguchi H, Oguma E, Kayama F. The effects of iron defi-ciency on oestradiol-induced suppression of erythropoietin induction in rats: implications of pregnancy-related aanemia. Blood. 2005;106:67-74. (Pubitemid 40967176)
20. Anagnostou A, Zander A, Barone J, Fried W. Mechanism of the increased splenic erythropoiesis in mice treated with oestradiol benzoate. J Lab Clin Med. 1976;88:700-6.